Implantable cardioverter-defibrillator eligibility after initiation of sacubitril/valsartan in chronic heart failure: insights from PROVE-HF
Current guidelines recommend implantable cardio-verter-defibrillator (ICD) implantation for
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
[HTML][HTML] Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
GM Felker, J Butler, NE Ibrahim, IL Piña, A Maisel… - Circulation, 2021 - ncbi.nlm.nih.gov
Current guidelines recommend implantable cardio-verter-defibrillator (ICD) implantation for
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
[PDF][PDF] Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
GM Felker, J Butler, NE Ibrahim, IL Piña - Circulation, 2021 - academia.edu
Current guidelines recommend implantable cardio-verter-defibrillator (ICD) implantation for
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
GM Felker, J Butler, NE Ibrahim, IL Piña… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in
Chronic Heart Failure: Insights From PROVE-HF Implantable Cardioverter-Defibrillator …
Chronic Heart Failure: Insights From PROVE-HF Implantable Cardioverter-Defibrillator …
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
GM Felker, J Butler, NE Ibrahim, IL Piña - Circulation, 2021 - Am Heart Assoc
Current guidelines recommend implantable cardio-verter-defibrillator (ICD) implantation for
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
[PDF][PDF] Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
GM Felker, J Butler, NE Ibrahim, IL Piña - Circulation, 2021 - researchgate.net
Current guidelines recommend implantable cardio-verter-defibrillator (ICD) implantation for
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
GM Felker, J Butler, NE Ibrahim, IL Piña, A Maisel… - Circulation, 2021 - europepmc.org
Current guidelines recommend implantable cardio-verter-defibrillator (ICD) implantation for
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
[PDF][PDF] Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF
GM Felker, J Butler, NE Ibrahim, IL Piña - Circulation, 2021 - pdfs.semanticscholar.org
Current guidelines recommend implantable cardio-verter-defibrillator (ICD) implantation for
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …
prevention of sudden death in patients with heart failure (HF) and reduced ejection fraction …